Welcome to our dedicated page for Nephros news (Ticker: NEPH), a resource for investors and traders seeking the latest updates and insights on Nephros stock.
Nephros, Inc. (Nasdaq: NEPH) is a water technology company focused on filtration products, services, and water-quality education for medical, healthcare, commercial, and industrial markets. The NEPH news feed highlights how the company’s filtration solutions and educational initiatives are applied in practice, as well as how its financial performance evolves over time.
News about Nephros often includes quarterly and year-to-date financial results, where the company reports net revenue, net income or loss, gross margin, and adjusted EBITDA. These updates frequently discuss programmatic revenue tied to recurring filter use, emergency response sales related to compromised water events, and trends in service revenue. Investors can use these releases to understand how Nephros’ programmatic business and active customer sites are developing across infection control, dialysis water, and commercial segments.
The NEPH news stream also covers product launches and technology developments. Examples include new filtration products designed to support compliance with water quality standards and to extend Nephros’ technology into additional medical, commercial, and industrial applications. These announcements explain how new offerings fit within the company’s portfolio and which types of facilities or industries they are intended to serve.
Another recurring theme in Nephros news is water safety education. The company reports on webinars, speaking engagements, and the activities of the Nephros Water Institute, which provides regulatory and risk-based educational programming for professionals responsible for water systems. Together, these financial, product, and educational updates give a rounded view of Nephros’ operations and strategic focus. Users interested in NEPH can review this page regularly for the latest company-issued press releases and related disclosures.
Nephros (Nasdaq: NEPH) announced expansion into Puerto Rico on Feb 13, 2026, targeting medical and commercial water filtration needs.
The company estimates a $10 million Puerto Rico market opportunity across healthcare ($3M), foodservice ($3M), hotels ($1M), other hospitality ($1M) and service contracts/replacements ($1M), and will offer local Spanish support, rapid fulfillment and on-site installation.
Nephros (Nasdaq: NEPH) launched the Nephros Water Institute to formalize and expand its national water-safety education efforts. In 2025 the company reached nearly 1,000 professionals through webinars, national talks, and trainings addressing ASHRAE 514, AAMI ST108, and emergency preparedness.
The Institute will deliver a structured, evidence-based curriculum and a monthly 2026 calendar covering Joint Commission guidance, worker safety at sinks/eyewash stations, construction water-safety links, compounding water quality, federal potable-water expectations, and dialysis water purity.
Nephros (Nasdaq: NEPH) reported third-quarter results for the period ended September 30, 2025, with Q3 net revenue $4.8M (up 35% year-over-year) and Q3 net income $0.3M (up 84% year-over-year), marking the company’s fourth consecutive profitable quarter.
For the nine months ended Sept 30, 2025, net revenue was $14.1M (up 37% YTD) and net income was $1.1M versus a $0.3M loss in prior year; Adjusted EBITDA improved to $1.44M YTD. The company reported cash and equivalents $5.2M and zero debt. Programmatic revenue showed strong growth (Q3 +51%; YTD +35%) and a new PFAS filtration product launched in early October.
Nephros (Nasdaq: NEPH) will file its third-quarter 2025 financial results on Thursday, November 6, 2025 after market close and will host a conference call the same day at 4:30 PM ET.
Participants can join via domestic dial 1 (844) 808-7106 or international dial 1 (412) 317-5285 and should ask to be joined into the Nephros conference call. An audio archive will be posted on the Nephros Investor Relations page shortly after the call.
A replay is available through November 13, 2025 by calling 1 (877) 344-7529 (U.S.) or 1 (412) 317-0088 (international) and entering replay access code 7475880.
Nephros (NASDAQ: NEPH) launched the 19-Series PFAS Filter on October 8, 2025, a point-of-use filter designed to reduce Total PFAS in potable water.
The filter is independently tested to NSF Standards 42 and 53, validated to reduce Total PFAS including PFOA and PFOS, and also reduces lead, asbestos, cysts, chlorine, taste, and odor. Product specs include a 3,145-gallon capacity and 1.63 GPM flow rate. Target customers include healthcare, daycares, education, foodservice, and manufacturing. Performance data is available on the product page.
Nephros (NASDAQ:NEPH), a water technology company, reported outstanding Q2 2025 financial results with significant growth and continued profitability. The company achieved net revenue of $4.4 million, marking a 36% increase year-over-year, and recorded its third consecutive profitable quarter with net income of $237,000.
Key highlights include a record-high programmatic sales performance, the largest dialysis filtration purchase order in company history, and all-time high active-site counts across all segments. The company's gross margin improved to 63%, up from 59% in Q2 2024, while maintaining a strong cash position of $5.1 million with no debt.
For the first half of 2025, Nephros reported net revenue of $9.3 million, up 37% year-over-year, with net income of $795,000 and Adjusted EBITDA of $1 million, demonstrating sustained growth and operational excellence.
Nephros (Nasdaq: NEPH), a water technology company specializing in filtration solutions for medical and commercial markets, has scheduled its second quarter 2025 financial results announcement for August 07, 2025 after market close.
The company will host a conference call at 4:30 PM ET on the same day. Investors can access the call through domestic (1-844-808-7106) or international (1-412-317-5285) lines. A replay will be available until August 15, 2025, using access code 6362809.
Nephros (Nasdaq: NEPH), a leading water technology company specializing in medical and commercial filtration solutions, has announced its participation in the Benchmark Company 13th Annual Discovery One-on-One Investor Conference. The event will take place on December 11, 2024, at the New York Athletic Club in New York City.
CEO Robert Banks and CFO Judy Krandel will represent Nephros at the conference, conducting one-on-one and group meetings with investors and analysts throughout the day. The conference format is designed to connect emerging growth companies with institutional and individual investors.
Nephros reported Q3 2024 financial results with net revenue of $3.5 million, marking an 8% increase over Q2 2024 but a 6% decrease from Q3 2023. The company achieved its first profitable quarter with net income of $0.2 million, compared to a net loss of $0.2 million in Q3 2023. Gross margins improved to 61% from 59% year-over-year. Adjusted EBITDA reached $295,000, up from $11,000 in the same period last year. Cash position stood at $2.5 million as of September 30, 2024, down from $4.3 million at the end of 2023.
Nephros (Nasdaq: NEPH), a water technology company specializing in filtration solutions for healthcare and commercial markets, announced it will release its third-quarter 2024 financial results on Thursday, November 7, 2024, after market close. The company will host a conference call at 4:30pm ET the same day. Participants can join via domestic access (1-844-808-7106) or international access (1-412-317-5285). An audio archive will be available on the Nephros Investor Relations page, with replay access until November 14, 2024.